Determination of ABCB1 polymorphisms and haplotypes frequencies in a French population (Q57994984)

8

object named as

Sophie Visvikis-Siest

0 references

author name string

Elise Jeannesson

1

0 references

Laetitia Albertini

2

0 references

Gérard Siest

3

0 references

Ana-Margarida Gomes

4

0 references

Charalampos Aslanidis

6

0 references

Gerd Schmitz

Fundamental and Clinical Pharmacology

7

0 references

publication date

August 2007

0 references

published in

0 references

volume

21

0 references

issue

4

0 references

page(s)

411-418

0 references

cites work

Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00507.X

Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00507.X

Multidrug resistance (MDR1) P-glycoprotein enhances esterification of plasma membrane cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00507.X

The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00507.X

Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00507.X

The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00507.X

Functional implications of genetic polymorphisms in the multidrug resistance gene MDR1 (ABCB1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00507.X

MDR1 Ala893 polymorphism is associated with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00507.X

Polymorphisms in the multidrug resistance-1 (MDR1) gene influence the response to atorvastatin treatment in a gender-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00507.X

Objectives, Design and Recruitment of a Familial and Longitudinal Cohort for Studying Gene-Environment Interactions in the Field of Cardiovascular Risk: The Stanislas Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00507.X

A simple salting out procedure for extracting DNA from human nucleated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00507.X

CYP3A4 and MDR1 alleles in a Portuguese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00507.X

Specific haplotypes of the P-selectin gene are associated with myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00507.X

CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00507.X

Single nucleotide polymorphisms of ABCB1 (MDR1) gene and distinct haplotype profile in a West Black African population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00507.X

C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00507.X

MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00507.X

Analysis of MDR1 haplotypes in Parkinson's disease in a white population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00507.X

Frequency distribution of C3435T mutation in exon 26 of the MDR1 gene in a Spanish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00507.X

Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00507.X

Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00507.X

Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00507.X

Identification of functionally variant MDR1 alleles among European Americans and African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00507.X

MDR1 genotype is associated with hepatic cytochrome P450 3A4 basal and induction phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2007.00507.X